Hyperhomocysteinemia and Cardiovascular Risk: Effect of Vitamin Supplementation in Risk Reduction

被引:41
作者
Ciaccio, Marcello [1 ]
Bellia, Chiara [1 ]
机构
[1] Univ Palermo, Fac Med, Dept Med Biotechnol & Forens Med, Palermo, Italy
来源
CURRENT CLINICAL PHARMACOLOGY | 2010年 / 5卷 / 01期
关键词
Homocysteine; MTHFR; cardiovascular disease; folate; B vitamins;
D O I
10.2174/157488410790410551
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Homocysteine is a sulfur-containing aminoacid produced during metabolism of methionine. Since 1969 the relationship between altered homocysteine metabolism and both coronary and peripheral atherotrombosis has been known; in recent years experimental evidences have shown that elevated plasma levels of homocysteine are associated with an increased risk of atherosclerosis and cardiovascular ischemic events. Several mechanisms by which elevated homocysteine impairs vascular function have been proposed, including impairment of endothelial function, production of Reactive Oxygen Species (ROS) and consequent oxidation of low-density lipids. Folic acid and B vitamins, required for remethylation of homocysteine to methionine, are the most important dietary determinants of homocysteinemia and daily supplementation typically lowers plasma homocysteine levels. Recently, large-scale intervention trials have been conducted to determine whether lowering homocysteine concentrations through B vitamins supplementation can decrease cardiovascular risk in healthy subjects or improve survival in patients with coronary heart disease. Some of these trials found no significant beneficial effects of combined treatment with folate and vitamin B-12, with or without vitamin B-6, in spite of adequate homocysteine lowering. In conclusion, it is still unclear whether decreasing plasma levels of homocysteine through diet or drugs may be paralleled by a reduction in cardiovascular risk.
引用
收藏
页码:30 / 36
页数:7
相关论文
共 62 条
[1]   Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease - A randomized trial [J].
Albert, Christine M. ;
Cook, Nancy R. ;
Gaziano, J. Michael ;
Zaharris, Elaine ;
MacFadyen, Jean ;
Danielson, Eleanor ;
Buring, Julie E. ;
Manson, JoAnn E. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (17) :2027-2036
[2]   Hyperhomocysteinemia activates nuclear factor-κB in endothelial cells via oxidative stress [J].
Au-Yeung, KKW ;
Woo, CWH ;
Sung, FL ;
Yip, JCW ;
Siow, YL ;
O, K .
CIRCULATION RESEARCH, 2004, 94 (01) :28-36
[3]   Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease [J].
Austin, RC ;
Lentz, SR ;
Werstuck, GH .
CELL DEATH AND DIFFERENTIATION, 2004, 11 (Suppl 1) :S56-S64
[4]   Effect of folic acid supplementation on risk of cardiovascular diseases - A meta-analysis of randomized controlled trials [J].
Bazzano, Lydia A. ;
Reynolds, Kristi ;
Holder, Kevin N. ;
He, Jiang .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (22) :2720-2726
[5]  
Boger RH, 2001, CLIN SCI, V100, P161, DOI 10.1042/CS20000173
[6]   Homocysteine lowering and cardiovascular events after acute myocardial infarction [J].
Bonaa, KH ;
Njolstad, I ;
Ueland, PM ;
Schirmer, H ;
Tverdal, A ;
Steigen, T ;
Wang, H ;
Nordrehaug, JE ;
Arnesen, E ;
Rasmussen, K .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (15) :1578-1588
[7]  
Bostom AG, 1999, J AM SOC NEPHROL, V10, P891
[8]   A QUANTITATIVE ASSESSMENT OF PLASMA HOMOCYSTEINE AS A RISK FACTOR FOR VASCULAR-DISEASE - PROBABLE BENEFITS OF INCREASING FOLIC-ACID INTAKES [J].
BOUSHEY, CJ ;
BERESFORD, SAA ;
OMENN, GS ;
MOTULSKY, AG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (13) :1049-1057
[9]   Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease -: The result of a meta-analysis [J].
Brattström, L ;
Wilcken, DEL ;
Öhrvik, J ;
Brudin, L .
CIRCULATION, 1998, 98 (23) :2520-2526
[10]   HOMOCYSTEINE EXPORT FROM CELLS CULTURED IN THE PRESENCE OF PHYSIOLOGICAL OR SUPERFLUOUS LEVELS OF METHIONINE - METHIONINE LOADING OF NONTRANSFORMED, TRANSFORMED, PROLIFERATING, AND QUIESCENT CELLS IN CULTURE [J].
CHRISTENSEN, B ;
REFSUM, H ;
VINTERMYR, O ;
UELAND, PM .
JOURNAL OF CELLULAR PHYSIOLOGY, 1991, 146 (01) :52-62